HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression

Eur J Immunol. 2010 Sep;40(9):2493-505. doi: 10.1002/eji.201040340.

Abstract

Co-infection of HCV with HIV has been associated with more rapid progression of HCV-related disease. HCV-specific T-cell immune responses, which are essential for disease control, are attenuated in co-infection with HIV. T-cell exhaustion has recently been implicated in the deficient control of chronic viral infections. In the current study, we investigated the role of programmed death-1 (PD-1) and T-cell immunoglobulin and mucin domain-containing molecule-3 (Tim-3) expression in T-cell exhaustion during HCV/HIV co-infection. We show that in HCV/HIV co-infection, both total and HCV-specific T cells co-express Tim-3 and PD-1 in significantly higher frequencies, compared with HCV mono-infection. Co-expression of these two markers on HCV-specific CD8(+) T cells positively correlated with a clinical parameter of liver disease progression. HCV-specific CD8(+) T cells showed greater frequencies of Tim-3/PD-1 co-expression than HIV-specific CD8(+) T cells, which may indicate a greater degree of exhaustion in the former. Blocking Tim-3 or PD-1 pathways restored both HIV- and HCV-specific CD8(+) T-cell expansion in the blood of co-infected individuals. These data demonstrate that co-expression of Tim-3 and PD-1 may play a significant role in HCV-specific T-cell dysfunction, especially in the setting of HIV co-infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Blocking / pharmacology
  • Antigens, CD / genetics
  • Antigens, CD / immunology
  • Antigens, CD / metabolism*
  • Antigens, Viral / immunology
  • Apoptosis Regulatory Proteins / genetics
  • Apoptosis Regulatory Proteins / immunology
  • Apoptosis Regulatory Proteins / metabolism*
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / metabolism*
  • CD8-Positive T-Lymphocytes / pathology
  • CD8-Positive T-Lymphocytes / virology
  • Cell Proliferation / drug effects
  • Cell Separation
  • Cells, Cultured
  • Disease Progression
  • Female
  • Flow Cytometry
  • HIV Infections / complications
  • HIV Infections / immunology*
  • HIV Infections / pathology
  • HIV Infections / physiopathology
  • HIV-1 / immunology*
  • HIV-1 / pathogenicity
  • HLA-A Antigens / immunology
  • HLA-A Antigens / metabolism
  • HLA-A2 Antigen
  • Hepacivirus / immunology*
  • Hepacivirus / pathogenicity
  • Hepatitis A Virus Cellular Receptor 2
  • Hepatitis C / complications
  • Hepatitis C / immunology*
  • Hepatitis C / pathology
  • Hepatitis C / physiopathology
  • Humans
  • Liver / immunology
  • Liver / pathology
  • Liver / virology
  • Male
  • Membrane Proteins / genetics
  • Membrane Proteins / immunology
  • Membrane Proteins / metabolism*
  • Programmed Cell Death 1 Receptor

Substances

  • Antibodies, Blocking
  • Antigens, CD
  • Antigens, Viral
  • Apoptosis Regulatory Proteins
  • HAVCR2 protein, human
  • HLA-A Antigens
  • HLA-A*02:01 antigen
  • HLA-A2 Antigen
  • Hepatitis A Virus Cellular Receptor 2
  • Membrane Proteins
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor